Literature DB >> 1357034

Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis.

M G Niemialtowski1, B T Rouse.   

Abstract

Herpetic stromal keratitis (HSK) appears to represent an immunopathologic response in the cornea of the eye to HSV-1. T cells of the CD4+ subset were shown to be involved in the mediation of HSK, but how they subserve an immunopathologic role is uncertain. In the present report, we have isolated cells from eyes in the active phase of HSK and studied their cytokine profile after culture in vitro or stimulation with Ag or nonspecific mitogens. Inflammatory cells recovered from eyes consist of polymorphonuclear leukocytes, macrophages, and lymphocytes. As reported before, all the lymphocyte recovered were of the CD4+ phenotype. After stimulation in vitro with Ag or mitogen the cytokines IL-2, IFN-gamma, and TNF-alpha/beta were produced, but not the cytokines IL-4 and IL-10. Thus, on the basis of cytokine profile, ocular lymphocytes were identified as Th1 cells. Ocular cells were also stimulated with PMA and shown to produce IL-1. The results were discussed in terms of the possible means by which the Th1 cells induce tissue damage in HSK as well as in terms of the possible means by which a preferential accumulation of Th1 cell occurs in the eye.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.

Authors:  E Chang; L Galle; D Maggs; D M Estes; W J Mitchell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  [Do antisense oligonucleotides improve viral immunopathology?].

Authors:  S Wasmuth; D Bauer; K P Steuhl; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

3.  Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.

Authors:  Naveen K Rajasagi; Pradeep B J Reddy; Amol Suryawanshi; Sachin Mulik; Per Gjorstrup; Barry T Rouse
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

4.  The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions.

Authors:  Siddheshvar Bhela; Siva Karthik Varanasi; Ujjaldeep Jaggi; Sarah S Sloan; Naveen K Rajasagi; Barry T Rouse
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

5.  Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

Authors:  Sharvan Sehrawat; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge.

Authors:  H Ghiasi; S L Wechsler; S Cai; A B Nesburn; F M Hofman
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes.

Authors:  S Chun; M Daheshia; N A Kuklin; B T Rouse
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis.

Authors:  Sherrie J Divito; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.

Authors:  Deepak Sumbria; Engin Berber; Barry T Rouse
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

10.  Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.

Authors:  Dirk Bauer; Andreas Schmitz; Nico Van Rooijen; Klaus-Peter Steuhl; Arnd Heiligenhaus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.